Navigation Links
Thought Leaders in Europe and US Address Challenges to Making Rare Diseases a Global Public Health Priority
Date:2/28/2011

ortance of harmonization between the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) to reduce the cost of clinical trials, especially for makers of therapies used to treat small rare disease populations, was another key issue analyzed by the participants. Clinical trials for rare disease therapies can cost more than 75 million euro ($100 million). As a result, Dr. Hammarstrom said some necessary clinical trials will never be done. "This means that certain types of therapies will be unavailable on both sides of the Atlantic," he said.

In addition, according to Peter Turner, Europe and the US are seldom aligned on clinical trial design. "Quite often we have to design a European trial and then a US trial because of requirements differing across the Atlantic," Mr. Turner explained. Yann Le Cam noted that EURORDIS has been working toward a solution by partnering with the EMA and the FDA on a retrospective analysis of orphan drug designations versus applications to better understand potential common approaches to new therapies. "There were many more commonalities than differences," Mr. Le Cam said. "Ninety-two percent of the decisions were the same."  

AvailabilityThere is a further complication in that the availability of treatments for rare diseases differs from country to country. According to Peter Saltonstall, if a therapy has been used on patients for period of time in Europe and the European safety and efficacy standards have been demonstrated, it is important to find a way to apply that information within the U.S. market.  "There needs to be a way for patients to get the drugs and therapies more quickly," Mr. Saltonstall said.

Yann Le Cam pointed out that globally, 80-85% of people with rare diseases are treated with off-label drugs and therapies. "We should encourage the collection of data during off-label use, both on safety and efficacy. This would be good medical practice that can lead to better
'/>"/>

SOURCE CSL Behring
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. intendiX - Communication by Thoughts: First Patient-Ready System on the Market
2. Emergency Nurses Association Announces Corporate Sponsors for Leadership Conference
3. PharmAthene Strengthens Scientific Leadership and Program Management for Future Growth
4. Safe and Secure TV Channel Expanding Programming and Revenue Agreements for 2011 with Pentagons Military News Channel and other Security Industry Leaders
5. Science advisor to the US EPA to speak to industry, academic leaders on sustainability innovations
6. InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet™ (Pirfenidone) in Europe
7. A New BioPharma Intelligence Resource Set to Give Industry Leaders the Edge
8. Biopharma Leaders to Reveal Successful Strategies for China, India at the PharmAsia Summit in San Francisco
9. iPierian Expands Leadership Team With Experienced Business Development and Intellectual Property Executives
10. BioStorage Technologies Brings Together Industry Leaders for Global Sample Management Benchmarking Symposium
11. Medix Uses Globalpark to Glean Insights From Over 20,000 Opinion Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... German . , ... in a semiconductor layer. Quantum dots are small structures that ... a short laser pulse is fired at the photonic crystal, ... a change in the electromagnetic field around it. This change ... by the dot. As soon as the refractive index recovers ...
(Date:9/30/2014)... Sept. 30, 2014 Report Details ... highest potential revenues Do you want to find ... you revenue predictions for those biological drugs from ... you find financial data, R&D trends, opportunities and ... sales forecasts to 2024 at overall world market, ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Follow ... level of each type of cholesterol carrier or lipoprotein ... presence of excessive cholesterol levels in the body, especially ... condition to heart attack and other cardiovascular disorders. Cardiovascular ... therefore testing for cholesterol levels on a regular basis, ...
(Date:9/30/2014)... OriginOil Inc. (OTC/QB: OOIL), developer of ... clean up large quantities of water, announced today that ... on the launch of the company's CLEAN-FRAC™ industrial grade ... partner STW Resources . , Immediately upon startup, ... (bpd) and achieved a 99.8% reduction in Turbidity on ...
Breaking Biology Technology:Ultrafast remote switching of light emission 2Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 2Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 3Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 4Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 5Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 2Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 3Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 4OriginOil, Inc. Report to Shareholders: Blue Gold in West Texas 2
... provide a golden opportunity to tune your talent strategy. ... have calmed, the long-term winners will be those firms ... Real competitive advantage comes from making a clear ... your talent management practice to that choice, even when ...
... BioSurfaces, Inc., a privately held UWMadison biotechnology spin-off, announced ... to its Scientific Advisory Board. , ,"Tom's extensive scientific ... writing, intellectual property management, and new product development make ... its next stage of growth," said Bryce P. Nelson, ...
... it lead in cutting-edge field , ,MARSHFIELD, WI - ... genetic research laboratory might have problems locating Marshfield on a ... at what is arguably ground zero for the burgeoning field ... Marshfield Clinic would have to be their first stop. ...
Cached Biology Technology:Talent Constellations or Talent Communities Choosing the Right Talent 2Talent Constellations or Talent Communities Choosing the Right Talent 3GenTel Appoints Burke to its Scientific Advisory Board 2Marshfield Clinic charges ahead in genetic research 2Marshfield Clinic charges ahead in genetic research 3Marshfield Clinic charges ahead in genetic research 4Marshfield Clinic charges ahead in genetic research 5
(Date:9/30/2014)... Calif. The National Institutes of Health (NIH) ... today to develop an electrode array system that ... brain works through unprecedented resolution and scale. , ... to support President Obama,s BRAIN (Brain Research ... research effort to revolutionize our understanding of the ...
(Date:9/30/2014)... engineers, led by Clemson University associate professor Brian ... from the U.S. Department of Energy,s Experimental Program ... positive impact on South Carolina in the advancement ... , "Understanding the scientific and engineering needs for ... nuclear technologies is imperative if South Carolina is ...
(Date:9/30/2014)... Medicine reports positive results of a phase 1 ... of lung cancer marked by rearrangement of the gene ... advanced non-small cell lung cancer testing positive for ROS1 ... 3 complete responses and 33 partial responses. Median progression-free ... to resume its growth after being slowed by treatment ...
Breaking Biology News(10 mins):NIH taps lab to develop sophisticated electrode array system to monitor brain act 2NIH taps lab to develop sophisticated electrode array system to monitor brain act 3Researchers get $5.25 million to advance nuclear technologies in South Carolina 2NEJM: Crizotinib effective in Phase 1 trial against ROS1 lung cancer 2
... a groundbreaking study at the University of Minnesota, Extension ... with a water-based electrochemical activation system that disinfects, cleans ... electrolyzed water systems are not new, this system, developed ... it produces a pH-neutral solution that won't cause deterioration ...
... is being developed by researchers at Cardiff University. ... Aureus) are resistant to one of more conventional antibiotic ... infection. , A team in the School of Medicine's ... Wellcome Trust to commercially develop a protein based therapeutic ...
... Ph.D., a Predoctoral Researcher at the Stowers Institute for ... and an investigator with the Howard Hughes Medical Institute, ... paper that identifies a network of cyclic genes that ... in the embryo. , The paper was ...
Cached Biology News:
...
... and flexibility of the BDTM LSR, the first UV ... The BD LSR II has performance, capabilities, and ... Free up your high-performance cell sorter by moving your ... LSR II. The BD LSR II can be configured ...
... Flow Cytometer System is a full featured, two ... the C6 Flow Cytometer, CFlow Software, and a ... Cytometer System provides all the capabilities of the ... the price. The C6 Flow Cytometer System has ...
...
Biology Products: